International Patent: METHODS AND COMPOSITIONS FOR MODULATING EXPRESSION OF RBM39 AND/OR MSH3

GENEVA, Oct. 1 -- TRANSCRIPTA BIO, INC. filed a patent application (US2026/018920) for “METHODS AND COMPOSITIONS FOR MODULATING EXPRESSION OF RBM39 AND/OR MSH3”. With publication no. WO/2026/193281, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/404

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....